• MISBAHUDDIN AZHAR Regional Research Institute of Unani Medicine, Shahjahan Manzil, Near AMU Riding Club, Aligarh.
  • MUSTEHASAN Central Council for Research in Unani Medicine, Janakpuri, New Delhi, India.


Objective: Bazr-ul-Banj syn. Ajwain khurasani (Hyoscyamus niger Linn.) is one of the important drug mentioned in Unani literature. It mentioned by the great Unani philosopher Dioscorides (first century AD) in his treatise Kitab-al-Hashaish. According to Unani philosophy, Bazr-ul-Banj is in third-degree category according to its temperamental nature. H. niger Linn. contains tropane alkaloids in good quantity, mainly hyoscyamine and scopolamine.

Methods: Unani classical literature was searched from recent to past available in different libraries. For phytochemistry, pharmacology, and clinical studies to prove, the importance computerized databases such as Medline, PubMed, Ovid SP, Google Scholar, and Science-direct were searched. All the information of plant available in Urdu, Persian, Arabic, and studies published abstract were included in the study.

Results: Fourteen Unani books were referred and 18 pharmacological studies were recognized. The action of Bazr-ul-Banj mentioned in Unani classical literature are Hazim (Digestive), Mudammil (Cicatrizant), Mujaffif (Dessicant), Mukhaddir (Anesthetic), Munashshi (Narcotic), Munawwim (Hypnotic), Musakkin (Sedative), Musakkin-e-Alam (Analgesic), Raade (divertive), Qabiz (Astringent), etc., and useful in Amraz-e-asbania (nervous affections), Amraz-e-Raham (uterine spasm and pain), Dard wa Alam (pain), Ikhtelaj-e-Qalb (palpitation), Junoon (mania), Niqras (Gout), Zeequn Nafas (Bronchial asthma), etc. H. niger Linn. showed many pharmacological effects included antimicrobial, anticancer, analgesic, anti-inflammatory, antipyretic, antihypertensive, and antidiarrheal activities in different clinical and experimental studies.

Conclusion: This presentation is an attempt to showcase the action, uses mentioned in Unani literature, chemical constituent, and pharmacological and toxicological effects at one place. It may also observe that the drug is having many actions which may be beneficial in cases of COVID-19. It may be concluded this should be tested as adjuvant medicine in cases of COVID-19.

Keywords: Ajwain khurasani, Bazr-ul-Banj, Hyoscyamus niger Linn., Unani medicine


1. Azhar MU, Khanam D, Aslam M, Tajuddin, Jafri MA. Plants with nephrotoxic activity. J Sci Pharm 2004;5:97-103.
2. Azhar MU, Javed K, Jafri MA. Plant with nephroprotective activity. Hamdard Med 2005;48:33-43.
3. Azhar MU, Akhtar F, Aslam M, Anwar M, Tajuddin, Jafri MA. Nephroprotective activity of some herbal preparations. Hamdard Med 2005;49:110-5.
4. Azhar MU, Quddusi N, Anjum N, Akhtar J, Hannan A, Jamil SS. Care of skin through Unani system of medicine. Unimed Kulliyat 2009;4:9-12.
5. Azhar MU, Quddusi N, Parveen S, Tajuddin, Siddiqui KM, Siddiqui MK. Daa-us-sadaf (psoriasis) and role of herbal drugs. Hamdard Med 2010;53:51-7.
6. Azhar MU, Quddusi N, Akhtar J, Akram U, Anjum N, Hannan A. Pharmacologial activities of Shilajit (asphaltum)-a Unani drug. Indian J Unani Med 2011;4:5-8.
7. Azhar MU, Akhtar J, Akram U, Anjum N, Quddusi N. Pharmacological activity of holy drug-zaitoon (Olea europaea linn.)-review. Indian J Unani Med 2011;4:85-91.
8. Azhar MU, Anjum N, Quddusi N, Akhtar J, Akram U, Yadav PK. Pharmacologically active nephroprotective plants-a review. Hamdard Med 2013;56:56-76.
9. Azhar MU, Anjum N, Quddusi N. Pharmacological activity of khurma (Phoenix dactilifera Linn.). A review. Hamdard Med 2015;58:71-83.
10. Azhar MU, Anjum N, Quddusi N. Pharmacologically active cardioprotective plants at a glance. Hamdard Med 2015;58:51-83.
11. Akram M, Azhar MU. Revend (rhubarb): An important Unani drug for prevention of nephrotoxicity. Int J Pharm Prof Res 2016;7:1333-40.
12. Anjum N, Quddusi N, Azhar MU. Phytopharmacological aspects of bisehri booti (Aerva lanata) and its uses in Unani system of medicine-a review. Hippocratic J Unani Med 2017;12:51-64.
13. Azhar MU, Anjum N. Revand chini (Chinese rhubarb): A review on historical and Unani classical prospect. Int J Unani Integr Med 2019;3:11-8.
14. Akram M, Azhar MU, Anjum N, Quddusi N. Phytopharmacology of Unani drug Zeerah siyah (Carum carvi linn)-a review. J Pharmacogn Phytochem 2019;8:2772-82.
15. Azhar MU, Mustehasan, Alam M, Ahmad SG, Anjum N, Quddusi N. Nephroprotective Unani drug khare-khasak khurd (Tribulus terrestris linn.)-a review. Int J Sci Res Biol Sci 2020;7:24-36.
16. Anonymous. The Wealth of India: A Dictionary of Raw Materials and Industrial Products, Raw Materials. Vol. 5. New Delhi: Publications and Information Directorate; 1997. p. 151-4.
17. Hocking GM. Henbane-healing herb of Hercules and of Appollo. Econ Bot 1947;1:306-16.
18. Bentley R, Trimen H. Medicinal Plants. London: J & A Churchill; 1880. p. 121.
19. Dymock W, Warden CJ, Hopper D. Pharmacographia Indica. Vol. 2. Dehradun: M/S Bishen Singh Mahendra Pal Singh; 1976. p. 313.
20. Volak J, Stodola J. The Illustrated Book of Herbs: Their Medicinal and Culinary Uses. London: Chancellor Press, Bounty Books; 1992.
21. Haas LF. Hyoscyamus niger (Henbane). J Neurol Neurosurg Psychiatry 1995;59:114.
22. Paulsen BP. Highlights through the history of plant medicine. In: Bernhoft A, editor. Bioactive Compounds in Plants-Benefits and Risks for Man and Animals. Oslo: Proceeding from a Symposium Held at the Norwegian Academy of Science and Letters; 2010.
23. Oztekin-Mat A. Plant poisoning cases in Turkey. Ann Pharm Fr 1994;52:260-5.
24. Fuchs J, Rauber-Luthy C, Kupferschmidt H, Kupper J, Kullak- Ublick GA, Ceschi A. Acute plant poisoning: Analysis of clinical features and circumstances of exposure. Clin Toxicol (Phila) 2011;49:671-80.
25. Moshiri M, Etemad L, Javidi S, Alizadeh A. Peganum harmala intoxication, a case report. Avicenna J Phytomed 2013;3:288-92.
26. Daneshvar S, Mirhossaini ME, Balali-Mood M. Hyoscyamus poisoning in Mashhad. Toxicon 1992;30:501.
27. Al-Snafi AE. Therapeutic importance of Hyoscyamus species grown in Iraq (Hyoscyamus albus, Hyoscyamus niger and Hyoscyamus reticulates)-a review. IOSR J Pharm 2018;8:18-32.
28. Ibn Baitar ZU. Kitab-al-Jami-ul-Mufradat-al Adwia-wal Aghzia. Vol. 1. New Delhi: Central council for Research in Unani Medicine Publication; 1985. p. 293-7.
29. Rafiquddin M. Kunzul Advia Mufrada. Aligarh: Aligarh Muslim University, University Publication Unit; 1985. p. 163-6.
30. Aziz MA. Mufradat-e-Azizi. Lucknow: Sahitya Mandir Press Ltd.; 1948. p. 5.
31. Ghani MN. Khazinatul Advia. Vol. 3. Lahore: Barqi Press; 1917. p. 21-5.
32. Hakeem MA. Bustan-ul-Mufradat. Lucknow: Taraqqi Urdu Publication; 1894. p. 54.
33. Kareem NA. Makhzanul Advia. Vol. 2. Kanpur: Munshi Nawal Kishore; 1888. p. 99.
34. Majoosi AA. Kamil-us-Sana. (Urdu Translation by Ghulam H Kantoori). Vol. 2. Lucknow: Munshi Nawal Kishore; 1889. p. 137.
35. Kabiruddin M. Makhzan-ul-Mufradat. Vol. 1. Hyderabad: National Fine Printing Press; 1955. p. 63.
36. Khan MA. Muheet-e-Azam. Vol. 1. New Delhi: Central Council for Research in Unani Medicine Publication; 1886. p. 751-4.
37. Ibn Sina BA. Al-Qanoon-Fit-Tib. (Urdu Translation by Ghulam Husain Kantoori). Vol. 2. Pakistan: Nigarshat Publishers; 1898. p. 152.
38. Ali SS. Unani Advia Mufrada. 5th ed. New Delhi: National Council for Promotion of Urdu Language; 1989. p. 76.
39. Hubal I. Kitab-al-Mukhtarat Fit Tib. Vol. 2. Hyderabad: Darul Ma’arif Al Islamias; 1943. p. 130.
40. Israili AM. Tarjuma-e-Aqsaraie. Vol. 1. Lucknow: Munshi Nawal Kishore; 1907. p. 803.
41. Lubhaya GR. Bayanul Advia. Vol. 1. New Delhi: Goswami Kutub Khana; 1984. p. 50.
42. Chopra RN, Chopra IC, Handa KL, Kapur LD. Indigenous Drugs of India. Kolkata: Academic Publishers; 1958. p. 134.
43. Nadkarni KM. Indian Materia Medica. Vol. 1. Bombay: Popular Prakashan; 1976. p. 670.
44. Kirtikar KR, Basu BD. Indian Medicinal Plants. Vol. 2. Dehradun: International Book Distribution; 1987. p. 1440.
45. Ambasta SP. The Useful Plants of India. New Delhi: Publication and Information Directorate, CSIR; 1986. p. 280.
46. Dey KL, Bahadur R, Mair W. Indigenous Drugs of India. New Delhi: Pama Primalane, The Chronia Botanica; 1973. p. 160.
47. Li R, Reed DW, Liu E, Nowak J, Pelcher LE, Page JE, et al. Functional genomic analysis of alkaloid biosynthesis in Hyoscyamus niger reveals a cytochrome P450 involved in littorine rearrangement. Chem Biol 2006;13:513-20.
48. Bernhoft A. A brief review on bioactive compounds in plants. In: Bioactive Compounds in Plants-Benefits and Risks for Man and Animals. Oslo: Proceedings from a Symposium Held at the Norwegian Academy of Science and Letters; 2010.
49. Begum S, Sahai M, Sussmuth R, Asai T, Hara N, Fujimoto Y. Hyosgerin (I), a new optically active coumarinolignan, from the seeds of Hyoscyamus niger. Chem Pharm Bull 2006;54:538-41.
50. Ma CY, Liu WK, Che CT. The flowering hormones. Ber Dtsch Bot Ges 2002;57:29-48.
51. Begum S, Saxena B, Goyal M, Ranjan R, Joshi VB, Rao CV, et al. Study of anti-inflammatory, analgesic and antipyretic activities of seeds of Hyoscyamus niger and isolation of a new coumarinolignan. Fitoterapia 2010;81:178-84.
52. Benhouda A, Yahia M. Toxicity, analgesic and anti-pyretic activities of methanolic extract from Hyoscyamus albus leaves in albinos rats. Planta Med 1999;65:60-3.
53. Massinissa Y, Affaf H, Mouloud Y. Analgesic, toxicity and anti-pyretic activities of methanolic extract from Hyoscyamus albus leaves in albinos rats. Int J Biotechnol Bioeng 2014;1:72.
54. Kiasalari Z, Khalili M, Khoshnevisan F. Evaluation of the effect of hydro-alcoholic extract of henbane seed on acute and chronic pain in male rats. Koomesh 2007;8:239-46.
55. Moradi M, Ghosian MH, Poor YE. Assessment of Hyoscyamus niger seeds alcoholic extract effects on acute and chronic pain in male NMRI rats. J Basic Clin Pathophysiol 2012;1:29-36.
56. Oto G, Ozdemir H, Yaren B, Yetkin Y, Tas A, Öztürk F, et al. Antinociceptive activity of methanol extract of Hyoscyamus reticulatus L. in mice. Am J Phytomed Clin Ther 2013;1:117-23.
57. Khan A, Gilani AH. In vivo studies on the bronchodilatory and analgesic activities of Hyoscyamus niger and Aspalathus linearis. Lat Am J Pharm 2010;29:777-82.
58. Kadi K, Yahia A, Hamli S, Auidane L, Khabthane H, Ali WK. In vitro antibacterial activity and phytochemical analysis of white henbane treated by phytohormones. Pak J Biol Sci 2013;16:984-90.
59. Ma CY, Liu WK, Che CT. Lignanamides and nonalkaloidal components of Hyoscyamus niger seeds. J Nat Prod 2002;65:206-9.
60. Reza HM, Mohammad H, Golnaz E, Gholamreza S. Effect of methanolic extract of Hyoscymus niger L. on the seizure induced by picritoxin in mice. Pak J Pharm Sci 2009;22:308-12.
61. Kiasalari Z, Khalili M, Heidari H, Azizi Y. Anti-convulsant effect of alcoholic Hyoscyamus niger L seed extract on PTZ model of kindling in male mice. Razi J Med Sci 2011;18:27-33.
62. Patil AD, Patil AY, Raje AA. Antidepressant like property of Hyoscyamus niger Linn. in mouse model of depression. Innov Pharm Pharmacother 2013;1:60-9.
63. Bourebaba L, Saci S, Touguit D, Gali L, Terkmane S, Oukil N, et al. Evaluation of antidiabetic effect of total calystegines extracted from Hyoscyamus albus. Biomed Pharmacother 2016;82:337-44.
64. Benhouda A, Yahia M, Khadhraoui H, Benbia S, Benhouda D. Hypoglycemic activity of methanolic extract of Hyoscyamus albus L. leaves in straptozotocin induced diabetic rats. Nat Prod Chem Res 2014;2:5.
65. Gilani AH, Khan AU, Raoof M, Ghayur MN, Siddiqui BS, Vohra W, et al. Gastrointestinal, selective airways and urinary bladder relaxant effects of Hyoscyamus niger are mediated through dual blockade of muscarinic receptors and Ca2+ channels. Fundam Clin Pharmacol 2008;22:87-99.
66. Khan AU, Gilani AH. Cardiovascular inhibitory effects of Hyoscyamus niger. Methods Find Exp Clin Pharmacol 2008;30:295-300.
67. Mohammad MK, Almasri IM, Tawaha K, Issa A, Al-Nadaf A, Hudaib M, et al. Antioxidant, antihyperuricemic and xanthine oxidase inhibitory activities of Hyoscyamus reticulatus. Pharm Biol 2010;48:1376-83.
68. Bustanji Y, Hudaib M, Tawaha K, Mohammad MK, Almasri I, Hamed S, et al. In vitro xanthine oxidase inhibition by selected Jordanian medicinal plants. Jordan J Pharm Sci 2011;4:49-56.
69. Benhouda A, Yahia M, Benhouda D, Bousnane NE, Benbia S, Hannachi NE, et al. Antimicrobial and antioxidant activities of various extracts of Hyoscyamus albus L. and Umbilicus rupestris L. leaves. Algerian J Nat Prod 2014;2:4-17.
70. Alghazeer R, El-Saltani H, Saleh N, Al-Najjar A, Hebail F. Antioxidant and antimicrobial properties of five medicinal Libyan plants extracts. Nat Sci 2012;4:324-35.
71. Dulger G, Dulger B. Antimicrobial activity of the seeds of Hyoscyamus niger L. (Henbane) on microorganisms isolated from urinary tract infections. J Med Plants Stud 2015;3:92-5.
72. Akhtar MS, GiII SA. Evaluation of anticlostridial efficacy of indigenous medicinal plant drugs: Rasoot, ajwain khurasani neem and bakain. Pak J Agric Sci 1992;29:371-5.
73. Mateen A, Tanveer Z, Janardhan K, Gupta VC. Screening and purification of antibacterial proteins and peptides from some of the medicinal plants seeds. Int J Pharm Bio Sci 2015;6:774-81.
74. Sengupta T, Vinayagam J, Nagashayana N, Gowda B, Jaisankar P, Mohanakumar KP. Antiparkinsonian effects of aqueous methanolic extract of Hyoscyamus niger seeds result from its monoamine oxidase inhibitory and hydroxyl radical scavenging potency. Neurochem Res 2011;36:177-86.
75. Mobin M, Khan MN, Abbas ZK. Ecotype difference in bioactive constituents and in vitro antioxidant activities of some Saudi medicinal plants. Eur J Med Plants 2015;7:125-36.
76. Souri E, Amin G, Dehmobed-Sharifabadi A, Nazifi A, Farsam H. Antioxidative activity of sixty plants from Iran. Iran J Pharm Res 2004;3:55-9.
77. Hajipoor K, Sani AM, Mohammadi A. In vitro antioxidant activity and phenolic profile of Hyoscyamus niger. Int J Biol Pharm Allied Sci 2015;4:4882-90.
78. Gune? E, Zengin G, Uysal A, Aktumsek A, Durak Y. A study on antioxidant and antimicrobial properties of hexane and water extracts from Hyoscyamus reticulates. SUFEFD 2014;39:21-9.
79. Khatri DK, Juvekar AR. Propensity of Hyoscyamus niger seeds methanolic extract to allay stereotaxically rotenone-induced Parkinson’s disease symptoms in rats. Orient Pharm Exp Med 2015;15:327-39.
80. Vallabi DE, Elango V. Preliminary studies on cardio protective effect of Hyoscyamus niger Linn in male albino rats. J Chem Pharm Res 2016;8:860-4.
81. Behravan M, Kakhki MR, Baharshahi A. Comparing larvicidal effect of methanol extract of the aerial parts of henbane (Hyoscyamus niger L.) and oleander (Nerium oleander L.) plants on Anopheles spp larvae (Diptera: Culicidae) in vitro. Zahedan J Res Med Sci 2017;19:e8631.
82. Daneshvar S, Mirhossaini ME, Balali-Mood M. Hyoscyamus poisoning in Mashhad. Toxicon 1992;30:501.
83. Craig OI. Emergencies in general practice: Poisons children swallow. Emerg Gener Pract 1975;17:1495-8.
84. Graev M, Fallani M. Collective poisoning caused by ingestion of Hyoscyamus niger (with a fatal case). Minerva Medicoleg 1960;80:225-30.
85. Tugrul L. Abuse of henbane by children in Turkey. Bull Narc 1985;37:75-8.
86. Anonymous. National Formulary of Unani Medicine, Part-I, Vol. I, New Delhi: Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Ministry of Health and Family Welfare, Government of India; 2006. p. 9, 19, 35, 41-2, 88, 154-5, 239.
87. Anonymous. National Formulary of Unani Medicine. Part-II, Vol. 1. New Delhi: Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Ministry of Health & Family Welfare, Government of India; 2007. p. 17,21,23-24,30-31,68,75,92-93.
88. Anonymous. National Formulary of Unani Medicine. Part-III, Vol. 1. New Delhi: Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Ministry of Health & Family Welfare, Government of India; 2001. p. 21,31-32,83.
89. Anonymous. National Formulary of Unani Medicine. Part-IV, Vol. 1. New Delhi: Department of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Ministry of Health & Family Welfare, Government of India; 2006. p. 108.
95 Views | 81 Downloads
How to Cite
AZHAR, M., and MUSTEHASAN. “PHYTOPHARMACOLOGY OF AN IMPORTANT UNANI DRUG BAZR-UL-BANJ (HYOSCYAMUS NIGER LINN.) – REVIEW”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 13, no. 9, Aug. 2020, pp. 28-32, doi:10.22159/ajpcr.2020.v13i9.38166.
Review Article(s)